An international panel of cancer genetic counselors with research and advocacy interests in LGBTQ+ affirming care, NHS Bristol’s Josephine Giblin, Dana-Farber Cancer Institute’s Diane Koeller, and Boston University School of Medicine’s Kimberly Zayhowski, discuss:Risk considerations for trans and gender diverse cancer genetic counseling patientsCreating safe and inclusive environments in cancer genetic counselingProtecting patients during times of unprecedented legislationResources and methods to support trans and gende...
An international panel of cancer genetic counselors with research and advocacy interests in LGBTQ+ affirming care, NHS Bristol’s Josephine Giblin, Dana-Farber Cancer Institute’s Diane Koeller, and Boston University School of Medicine’s Kimberly Zayhowski, discuss:
- Risk considerations for trans and gender diverse cancer genetic counseling patients
- Creating safe and inclusive environments in cancer genetic counseling
- Protecting patients during times of unprecedented legislation
- Resources and methods to support trans and gender diverse patients
Hosted by DNA Today's Kira Dineen.
Resources and further reading:
- Navigating sexual orientation and gender identity data privacy concerns in United States genetics practices
- NSGC Policy Statement: Distinguishing Sex and Gender to Reduce Harm
- TGD CanScreen Project
- Canadian Resource: Queering Cancer
- CoppaFeel: UK patient resource with gender based language selection
View more